Agomab Therapeutics NV (Agomab) has announced positive interim results from 44 patients completing treatment in the ongoing ...

Pfizer Ltd has announced that the Scottish Medicines Consortium (SMC) has accepted Talzenna (talazoparib) in combination with enzalutamide for the treatment of adult patients with metastatic ...

NICE’s interim second draft guidance does not recommend lecanemab for use within the NHS in England and Wales at this time.

Octapharma has announced that, for the first time in almost 30 years, NHS patients are receiving medicines made from ...

The Safety Review Committee (SRC) has confirmed the end of the Dose Escalation phase and the start of the cohort expansion ...

To reduce waiting lists and enhance patient communication, Rotherham NHS Foundation Trust has adopted Netcall’s Liberty for ...

Kenvue has appointed Bas Vorsteveld as Area Managing Director for Northern Europe. He will oversee Kenvue’s business in the ...

Centauri Therapeutics Limited has announced the selection of its first clinical candidate for the ABX-01 programme. The ...